MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Sells 1,082 Shares of Humana Inc. (NYSE:HUM)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lessened its position in Humana Inc. (NYSE:HUM) by 78.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 289 shares of the insurance provider’s stock after selling 1,082 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in Humana were worth $100,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Rakuten Securities Inc. bought a new stake in shares of Humana in the 4th quarter worth approximately $25,000. Gradient Investments LLC increased its position in Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares during the period. Cetera Trust Company N.A bought a new position in Humana in the 4th quarter worth $28,000. Private Wealth Management Group LLC purchased a new stake in shares of Humana in the 4th quarter worth about $32,000. Finally, Carolinas Wealth Consulting LLC boosted its stake in shares of Humana by 274.1% during the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after purchasing an additional 74 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. TD Cowen decreased their price target on shares of Humana from $427.00 to $396.00 and set a “buy” rating for the company in a research note on Tuesday, April 2nd. Bank of America increased their target price on Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research report on Monday, May 20th. Jefferies Financial Group dropped their price target on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. Robert W. Baird initiated coverage on Humana in a report on Thursday, May 30th. They issued a “neutral” rating and a $374.00 price objective for the company. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $360.00 target price on shares of Humana in a research report on Wednesday, June 12th. Fourteen analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus target price of $409.55.

Humana Price Performance

Shares of HUM opened at $374.82 on Wednesday. The firm has a market cap of $45.17 billion, a PE ratio of 23.34, a P/E/G ratio of 2.16 and a beta of 0.51. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The firm has a fifty day simple moving average of $344.75 and a two-hundred day simple moving average of $351.38. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the business posted $9.38 earnings per share. On average, equities analysts anticipate that Humana Inc. will post 16.27 EPS for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.